Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation

Abstract Aims Membrane‐bound angiotensin‐converting enzyme (ACE)2 is the main cellular access point for SARS‐CoV‐2, but its expression and the effect of ACE inhibition have not been assessed quantitatively in patients with heart failure. The aim of this study was to characterize membrane‐bound ACE2...

Descripció completa

Dades bibliogràfiques

Autors principals:	Johannes Bargehr, Patrick Rericha, Alex Petchey, Maria Colzani, Georgia Moule, Marie Chet Malgapo, Doris Rassl, Jason Tarkin, Greg Mellor, Fotis Sampaziotis, Teresa Brevini, Laure Gambardella, Martin R. Bennett, Sanjay Sinha
Format:	Artigo
Idioma:	Inglês
Publicat:	Oxford University Press 2021-10-01
Col·lecció:	ESC Heart Failure
Matèries:	COVID‐19; SARS‐CoV‐2; Heart failure; Heart transplantation; ACE inhibitor
Accés en línia:	https://doi.org/10.1002/ehf2.13528
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!